Gilman Steven C
- SEC CIK
- 0001379970
No open-market purchases or sales filed in the past year.
Current role at each company
- SCYX Scynexis IncDirectoras of Jun 30, 2025
- AKBA Akebia Therapeutics, Inc.Directoras of Jun 11, 2025
- VCEL Vericel CorpDirectoras of Oct 18, 2024
- CFRX CONTRAFECT CorpDirectoras of May 18, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gilman Steven C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VCEL Vericel Corp
Director8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2024 (view filing) | Oct 16 | 2 days | Gilman Steven CDirector | SSale | −5.83K | $41.36 | −$241.3K | −34.7%11.0K after | 10b5-1 |
| Oct 4, 2024 (view filing) | Oct 2 | 2 days | Gilman Steven CDirector | SSale | −5.83K | $40.35 | −$235.4K | −34.7%11.0K after | 10b5-1 |
| Sep 20, 2024 (view filing) | Sep 18 | 2 days | Gilman Steven CDirector | SSale | −5.83K | $45.54 | −$265.7K | −34.7%11.0K after | 10b5-1 |
| Sep 5, 2024 (view filing) | Sep 4 | 1 day | Gilman Steven CDirector | SSale | −5.00K | $48.58 | −$242.9K | −31.3%11.0K after | 10b5-1 |
| May 2, 2022 (view filing) | Apr 29 | 3 days | Gilman Steven CDirector | SSale | −900 | $30.94 | −$27.8K | −14.8%5.20K after | |
| Dec 1, 2021 (view filing) | Nov 29 | 2 days | Gilman Steven CDirector | SSale | −5.00K | $39.17 | −$195.8K | −58.8%3.50K after | |
| Oct 28, 2021 (view filing) | Oct 27 | 1 day | Gilman Steven CDirector | SSale | −5.00K | $50.57 | −$252.8K | −58.8%3.50K after | |
| Oct 1, 2021 (view filing) | Sep 30 | 1 day | Gilman Steven CDirector | SSale | −5.00K | $48.85 | −$244.3K | −58.8%3.50K after |
AKBA Akebia Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 (view filing)4:03 PM ET | Jun 3 | 4 days | Gilman Steven CDirector | SSale | −4.57K | $0.362 | −$1.65K | −9.5%43.4K after |